|Bid||0.0600 x 0|
|Ask||0.0650 x 0|
|Day's Range||0.0600 - 0.0700|
|52 Week Range||0.0300 - 0.1100|
|Beta (5Y Monthly)||1.50|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
New ISO 13485:2016 MDSAP scope paves the way to integration of novel and multiple bio sign monitoring devices for broader patient monitoring solution sales to the consumer and Rx markets globally Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leading global provider of consumer heart monitoring and electrocardiogram ("ECG") acquisition and management software solutions, has received approval on an expanded ISO 13485:2016 ("ISO") certification in ...
Toronto, Ontario--(Newsfile Corp. - January 10, 2021) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, is confirming the appointment of a new Chief Financial Officer and completion of a debt to equity settlement.On December 29, 2020, the Company announced that two of its four lenders had exercised their right to convert loans that had been recently renewed under ...
Debt to equity conversion follows new releasesTORONTO, ON / ACCESSWIRE / December 29, 2020 / CardioComm Solutions, Inc.